WallStSmart
LIVN

LivaNova PLC

NASDAQ: LIVN · HEALTHCARE · MEDICAL DEVICES

$58.92
-3.87% today

Updated 2026-04-29

Market cap
$3.51B
P/E ratio
P/S ratio
2.53x
EPS (TTM)
$-4.45
Dividend yield
52W range
$35 – $72
Volume
0.9M

LivaNova PLC (LIVN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+31.8%
Last 4 quarters
Revenue YoY growth
+12.1%
Most recent quarter
EPS YoY growth
+6.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.3%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-8.1%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-25$0.86+6.1%$69.05$71.00+2.8%
2025-11-05$1.11+20.7%$53.94$49.57-8.1%
2025-07-29$1.05+21.0%$43.46$44.01+1.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.81$0.86+6.1%$360.86M+12.1%
2025-09-30$0.92$1.11+20.7%$357.80M+12.5%
2025-06-30$0.87$1.05+21.0%$352.52M+10.7%
2025-03-31$0.49$0.88+79.6%$316.86M+7.4%
2024-12-31$0.80$0.81+1.2%$321.83M+3.8%
2024-09-30$0.72$0.90+25.0%$318.12M+11.2%
2024-06-30$0.78$0.93+19.2%$318.57M+8.4%
2024-03-31$0.49$0.73+49.0%$294.91M+12.0%
2023-12-31$0.77$0.87+13.0%$310.13M
2023-09-30$0.64$0.73+14.1%$286.11M
2023-06-30$0.54$0.78+44.4%$293.88M
2023-03-31$0.39$0.43+10.3%$263.42M

Frequently asked questions

Has LivaNova PLC beaten earnings estimates?
LivaNova PLC has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +31.8% over the last 4 quarters.
How does LIVN stock react to earnings?
LIVN stock has moved an average of -1.3% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is LivaNova PLC's revenue growth rate?
LivaNova PLC reported year-over-year revenue growth of +12.1% in its most recent quarter, with EPS growing +6.2% year-over-year.